查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827699

2025年全球自动注射器市场报告

Autoinjectors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，自动注射器市场呈指数级增长，市场规模从2024年的37亿美元增长至2025年的45.1亿美元，复合年增长率达22.0%。过去的成长可归因于慢性病盛行率的上升、人口老化加剧、生物技术和製药行业的兴起、偏好对自我注射的偏好日益增长以及监管支持。

预计未来几年自动注射器市场规模将呈指数级增长，到2029年将达到99.3亿美元，复合年增长率为21.8%。预测期内的成长可归因于治疗应用的不断扩展、医疗成本的不断上涨、对以患者为中心的护理、远端医疗和远端患者监护的日益关注，以及新兴市场的蓬勃发展。预测期间的主要趋势包括个人化给药、连网智慧自动注射器、无针自动注射器、生技药品输送、安全安全功能。

自动注射器是一种用于自行注射单剂量药物的装置，通常采用弹簧式註射器，透过对身体施加强力压力来启动。

自动注射器主要分为一次性和可重复使用两种类型。一次性自动注射器市场包括旨在取代传统预填充式注射器的设备，透过将针头隐藏在患者视线之外，消除了患者心理障碍。这些自动注射器整合了屏蔽针头和弹簧驱动机构，用于皮下或肌肉注射所需药物。它们可用于多种治疗，包括类风湿性关节炎、多发性硬化症、糖尿病和过敏反应，可透过皮下或肌肉注射途径给药。分销管道包括线上零售商和药局，并用于各种场所，包括居家医疗、医院和诊所。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、加强标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供自动注射器市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的自动注射器细分市场、市场趋势和机会，以及您在自动注射器行业取得成功所需的数据。本自动注射器市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长21.8%，较先前预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响将直接影响美国，导致德国精密弹簧和日本针头安全装置的供应延迟，可能会扰乱慢性病的治疗。此外，互惠关税以及贸易紧张局势加剧和限制措施对全球经济和贸易的负面影响也将更为广泛地显现。

预计未来几年慢性病盛行率的上升将推动自动注射器市场的成长。慢性病是指持续时间超过一年并需要持续治疗的疾病。心臟病、癌症、类风湿性关节炎和糖尿病等疾病是全球死亡和残疾的主要原因。自动注射器旨在为需要定期给药以长期治疗糖尿病和类风湿性关节炎等疾病的患者多次注射生技药品或荷尔蒙。例如，根据美国卫生组织美国癌症协会在 2022 年 1 月发布的一项调查，到那年，美国癌症死亡人数预计将达到 609,360 人，新增癌症病例预计将达到 190 万，相当于每天约有 1,670 人死亡。慢性病盛行率的上升推动了自动注射器市场的成长，因为这些设备为需要定期服药的患者提供了方便有效的解决方案。

预计不断增长的医疗支出将推动自动注射器市场的发展。医疗支出是指特定医疗体系或经济体在特定期间内用于医疗服务、商品和活动的总支出。医疗支出的成长促进了自动注射器的研发、价格承受能力和病患可近性。此外，对自动注射器日益增长的需求也推动了自动注射器开发领域的技术创新。例如，根据英国国家统计局2023年5月发布的报告，2020年至2021年，英国医疗保健支出名义成长9.4%，实际成长9.7%。 2021年，英国医疗保健总支出预计将达到3,672.5亿美元（2,807亿英镑），其中药品支出为518.4亿美元（396亿英镑），预防保健支出为459.3亿美元（351亿英镑），是2020年的两倍多。因此，不断增加的医疗保健支出在推动自动注射器市场方面发挥着重要作用。

技术进步正在显着影响自动注射器市场。自动注射器领域的主要参与企业正致力于开发创新解决方案，以满足黏性生技药品传输机制的需求。例如，2023年5月，德国製药公司勃林格殷格翰宣布，其用于Siltezo（Adalimumab-adbm）的自动注射器Siltezo Pen已获得美国食品药物管理局（FDA）的核准。 Siltezo已核准用于治疗各种慢性发炎性疾病。 40毫克/0.8毫升预填充Siltezo Pen有两支装、四支装和六支装可供选择。

为了满足对永续药物输送设备日益增长的需求，自动注射器市场的主要企业正专注于开发创新产品，并为自我给药输送提供更具成本效益的解决方案。 Qfinity 自动注射器平台就是这样一款创新产品，其设计既永续又价格实惠。该平台采用耐用材料，可承受 100 次以上的注射，并预填充盒式系统，可最大限度地减少废弃物。例如，2022 年 5 月，美国医疗保健製造商 Jabil Inc. 推出了 Qfinity 自动注射器平台。该平台为自我给药皮下 (SC) 药物（包括大容量、高黏度药物）提供了一种简单、可重复使用的模组化解决方案。它提供永续性、经济高效、多功能、易于使用、准确、安全、便携和耐用的自我给药输送。

2022年4月，美国生技公司Halozyme Therapeutics, Inc.以9.6亿美元收购了Antares Pharma。此次策略性收购旨在扩大Halozyme Therapeutics Inc.的药物传输技术组合，并获得Antares的商业基础设施。此次收购将使该公司成为药物传输领域的主要企业。 Antares是一家总部位于美国的药物研发公司，专注于自动注射器的开发。此次收购将使该公司能够向更广泛的市场提供包括自动注射器在内的创新药物输送解决方案。

自动注射器市场的主要企业包括 AbbVie Inc.、Mylan NV、Eli Lilly and Company、Amgen Inc.、Becton、Dickinson and Company、Johnson & Johnson、Teva Pharmaceutical Industries Ltd.、Merck & Co. Inc.Inc.、PfizerInc.、BayerAG、Biogen Inc.、Merck & Co. Inc.Inc.、PfizerInc.、BayerAG、Biogen Inc.、Astraself. Morris International Inc.、Oval Medical Technologies Ltd.、Solteam Incorporation Co. Ltd.、Elcam Medical Group (E3D) Ltd.、Jabil Inc.、Catalent Inc.、SHL Medical AG、West Pharmaceutical Services Inc.、Nemera Development SA、Bespak Europe Ltd.、AptarGrolc* Corporation、OssDsign AB、Xenco Medical LLC 和 Renishaw plc。

2024年，自动注射器市场最大的地区是北美。预计亚太地区将成为预测期内成长最快的地区。自动注射器市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

自动注射器市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

自动注射器市场涵盖一次性和可重复使用自动注射器的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售的商品价值，无论商品是销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）还是直接销售给最终客户。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球汽车注射器：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球自动注射器市场：成长率分析
  • 全球自动注射器市场表现：规模与成长，2019-2024
  • 全球自动注射器市场预测：规模与成长，2024-2029 年，2034 年
  • 全球自动注射器：总目标市场（TAM）

第六章 市场细分

  • 全球自动注射器市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 一次性自动注射器
  • 可重复使用的自动注射器
  • 全球自动注射器市场（按疗法、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 类风湿性关节炎
  • 多发性硬化症
  • 糖尿病
  • 过敏反应
  • 其他的
  • 全球自动注射器市场（依给药途径）：2019-2024 年、2024-2029 年、2034 年绩效及预测
  • 皮下
  • 肌肉注射
  • 全球自动注射器市场（依通路）：2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 线上零售商
  • 药局
  • 全球自动注射器市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 居家照护
  • 医院和诊所
  • 其他的
  • 全球自动注射器市场：一次性自动注射器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 一次性自动注射器
  • 预填充一次性自动注射器
  • 全球自动注射器市场：可重复使用自动注射器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 多功能可重复使用自动注射器
  • 充电可重复使用自动注射器

第七章 区域和国家分析

  • 全球自动注射器市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球自动注射器市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 自动注射器市场：竞争格局
  • 自动注射器市场：公司简介
    • AbbVie Inc.
    • Mylan NV
    • Eli Lilly and Company
    • Amgen Inc.
    • Becton, Dickinson and Company

第31章：其他领先和创新企业

  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Bayer AG
  • Biogen Inc.
  • AstraZeneca PLC
  • Haselmeier GmbH
  • Owen Mumford Ltd.
  • Gerresheimer AG
  • Philip Morris International Inc.
  • Oval Medical Technologies Ltd.
  • Solteam Incorporation Co. Ltd.
  • Elcam Medical Group（E3D）Ltd.
  • Jabil Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年自动注射器市场：提供新机会的国家
  • 2029 年自动注射器市场：细分市场带来新机会
  • 2029 年自动注射器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21032u

An autoinjector is a device designed for self-administering a single, predetermined dose of medication into the body. Typically, it features a spring-loaded syringe that is activated upon firm pressure against the body.

The primary types of autoinjectors are disposable autoinjectors and reusable autoinjectors. The market for disposable autoinjectors involves the sales of devices designed to replace traditional pre-filled syringes, aiming to eliminate psychological barriers by concealing the needle from the patient's view. These autoinjectors integrate a spring-powered mechanism with a shielded needle for subcutaneous or intramuscular administration of the required drug solution. They find application in various therapies such as rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others, administered through routes like subcutaneous and intramuscular. Distribution channels include online retailers and pharmacies, and they are utilized in diverse settings, including home care, hospitals, clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The autoinjectors market research report is one of a series of new reports from The Business Research Company that provides autoinjectors market statistics, including autoinjectors industry global market size, regional shares, competitors with an market share, detailed autoinjectors market segments, market trends and opportunities, and any further data you may need to thrive in the autoinjectors industry. This autoinjectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoinjectors market size has grown exponentially in recent years. It will grow from $3.7 billion in 2024 to $4.51 billion in 2025 at a compound annual growth rate (CAGR) of 22.0%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, growth in aging population, rise in biotechnology and pharmaceutical sector, rise in patient preference for self-administration, regulatory support.

The autoinjectors market size is expected to see exponential growth in the next few years. It will grow to $9.93 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to expansion of Therapeutic applications, rising healthcare costs, increased focus on patient-centered care, telemedicine and remote patient monitoring, emerging markets. Major trends in the forecast period include personalized drug delivery, connected and smart autoinjectors, needle-free autoinjectors, biologic drug delivery, safety and security features.

The forecast of 21.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through delays in acquiring German precision springs and Japanese needle safety mechanisms, potentially disrupting treatment for chronic conditions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is expected to drive growth in the autoinjectors market in the upcoming years. Chronic diseases are defined as illnesses that last for a year or longer and require ongoing medical attention. Conditions such as heart disease, cancer, rheumatoid arthritis, and diabetes are among the leading causes of mortality and disability worldwide. Autoinjector devices are designed for multiple injections of biologics and hormones in patients who need regular doses for the long-term management of conditions like diabetes and rheumatoid arthritis. For example, in January 2022, research published by the American Cancer Society, a US-based health organization, projected that there would be 609,360 cancer deaths and 1.9 million new cancer cases in the US for that year, which translates to approximately 1,670 fatalities each day. This rising prevalence of chronic diseases is propelling the growth of the autoinjectors market, as these devices offer a convenient and effective solution for patients requiring regular medication.

Rising healthcare expenditure is anticipated to boost the autoinjectors market. Healthcare expenditure refers to the total amount of money spent on healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. Increased healthcare expenditure supports the development, affordability, and accessibility of autoinjectors for patients. Moreover, greater demand for autoinjectors can drive innovation in the field of autoinjector development. As an illustration, according to a report published by the UK's Office for National Statistics in May 2023, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. In 2021, total healthcare expenditure in the UK reached $367.25 billion (£280.7 billion), with pharmaceutical expenditure at $51.84 billion (£39.6 billion), and spending on preventive care more than doubling from 2020, totaling $45.93 billion (£35.1 billion). Thus, rising healthcare expenditures are playing a significant role in propelling the autoinjectors market.

The rise of technological advancements is significantly influencing the autoinjectors market. Key players in the autoinjectors sector are concentrating on developing innovative solutions to fulfill the demand for a delivery mechanism for viscous biologics. For example, in May 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, announced that its Cyltezo Pen, an autoinjector option for Cyltezo (adalimumab-adbm), received approval from the U.S. Food and Drug Administration (FDA). Cyltezo is authorized for the treatment of various chronic inflammatory diseases. The 40 mg/0.8 mL pre-filled Cyltezo Pen will be available in packs of two, four, and six.

Major companies in the auto-injectors market are focused on developing innovative products to address the growing demand for sustainable drug delivery devices while offering more cost-effective solutions for self-administered drug delivery. One such innovative product is the Qfinity auto-injector platform, designed to be both sustainable and affordable. The platform incorporates durable materials capable of withstanding over 100 injections and features a pre-filled disposable cassette system that minimizes waste. For example, in May 2022, Jabil Inc., a US-based healthcare manufacturing company, introduced the Qfinity auto-injector platform. This platform is a straightforward, reusable, and modular solution for self-administering subcutaneous (SC) drugs, including larger-volume and higher-viscosity medicines. It offers sustainability, cost-effectiveness, versatility, ease of use, accuracy, safety, portability, and durability for self-administered drug delivery.

In April 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million. This strategic acquisition is aimed at expanding Halozyme Therapeutics Inc.'s portfolio of drug delivery technologies and gaining access to Antares' commercial infrastructure. The acquisition positions them to become a leading company in the field of drug delivery. Antares Pharma Inc. is a US-based pharmaceutical product development company specializing in the development of auto-injectors. This acquisition will likely enhance Halozyme's capabilities in delivering innovative drug delivery solutions, including auto-injectors, to a broader market.

Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc

North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autoinjectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The autoinjectors market consists of sales of disposable and reusable autoinjectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoinjectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoinjectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoinjectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autoinjectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Disposable Autoinjectors; Reusable Autoinjectors
  • 2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies
  • 3) By Route Of Administration: Subcutaneous; Intramuscular
  • 4) By Distribution Channel: Online Retailer; Pharmacy
  • 5) By End User: Home Care Settings; Hospitals And Clinics; Other End-Users
  • Subsegments:
  • 1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors; Pre-filled Disposable Autoinjectors
  • 2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors; Rechargeable Reusable Autoinjectors
  • Companies Mentioned: AbbVie Inc.; Mylan N.V.; Eli Lilly and Company; Amgen Inc.; Becton, Dickinson and Company; Johnson & Johnson; Teva Pharmaceutical Industries Ltd.; Merck & Co. Inc.; Pfizer Inc.; Bayer AG; Biogen Inc.; AstraZeneca PLC; Haselmeier GmbH; Owen Mumford Ltd.; Gerresheimer AG; Philip Morris International Inc.; Oval Medical Technologies Ltd.; Solteam Incorporation Co. Ltd.; Elcam Medical Group (E3D) Ltd.; Jabil Inc.; Catalent Inc.; SHL Medical AG; West Pharmaceutical Services Inc.; Nemera Development S.A.; Bespak Europe Ltd.; AptarGroup Inc.; Consort Medical plc; Terumo Corporation; Nipro Corporation; Medtronic plc; Integra LifeSciences Corporation; OssDsign AB; Xenco Medical LLC; Renishaw plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autoinjectors Market Characteristics

3. Autoinjectors Market Trends And Strategies

4. Autoinjectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Autoinjectors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Autoinjectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Autoinjectors Market Growth Rate Analysis
  • 5.4. Global Autoinjectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Autoinjectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Autoinjectors Total Addressable Market (TAM)

6. Autoinjectors Market Segmentation

  • 6.1. Global Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • 6.2. Global Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies
  • 6.3. Global Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Subcutaneous
  • Intramuscular
  • 6.4. Global Autoinjectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online Retailer
  • Pharmacy
  • 6.5. Global Autoinjectors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Home Care Settings
  • Hospitals And Clinics
  • Other End-Users
  • 6.6. Global Autoinjectors Market, Sub-Segmentation Of Disposable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Disposable Autoinjectors
  • Pre-filled Disposable Autoinjectors
  • 6.7. Global Autoinjectors Market, Sub-Segmentation Of Reusable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-Use Reusable Autoinjectors
  • Rechargeable Reusable Autoinjectors

7. Autoinjectors Market Regional And Country Analysis

  • 7.1. Global Autoinjectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Autoinjectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autoinjectors Market

  • 8.1. Asia-Pacific Autoinjectors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autoinjectors Market

  • 9.1. China Autoinjectors Market Overview
  • 9.2. China Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autoinjectors Market

  • 10.1. India Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autoinjectors Market

  • 11.1. Japan Autoinjectors Market Overview
  • 11.2. Japan Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autoinjectors Market

  • 12.1. Australia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autoinjectors Market

  • 13.1. Indonesia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autoinjectors Market

  • 14.1. South Korea Autoinjectors Market Overview
  • 14.2. South Korea Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autoinjectors Market

  • 15.1. Western Europe Autoinjectors Market Overview
  • 15.2. Western Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autoinjectors Market

  • 16.1. UK Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autoinjectors Market

  • 17.1. Germany Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autoinjectors Market

  • 18.1. France Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autoinjectors Market

  • 19.1. Italy Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autoinjectors Market

  • 20.1. Spain Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autoinjectors Market

  • 21.1. Eastern Europe Autoinjectors Market Overview
  • 21.2. Eastern Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autoinjectors Market

  • 22.1. Russia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autoinjectors Market

  • 23.1. North America Autoinjectors Market Overview
  • 23.2. North America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autoinjectors Market

  • 24.1. USA Autoinjectors Market Overview
  • 24.2. USA Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autoinjectors Market

  • 25.1. Canada Autoinjectors Market Overview
  • 25.2. Canada Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autoinjectors Market

  • 26.1. South America Autoinjectors Market Overview
  • 26.2. South America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autoinjectors Market

  • 27.1. Brazil Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autoinjectors Market

  • 28.1. Middle East Autoinjectors Market Overview
  • 28.2. Middle East Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autoinjectors Market

  • 29.1. Africa Autoinjectors Market Overview
  • 29.2. Africa Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autoinjectors Market Competitive Landscape And Company Profiles

  • 30.1. Autoinjectors Market Competitive Landscape
  • 30.2. Autoinjectors Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Autoinjectors Market Other Major And Innovative Companies

  • 31.1. Johnson & Johnson
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Merck & Co. Inc.
  • 31.4. Pfizer Inc.
  • 31.5. Bayer AG
  • 31.6. Biogen Inc.
  • 31.7. AstraZeneca PLC
  • 31.8. Haselmeier GmbH
  • 31.9. Owen Mumford Ltd.
  • 31.10. Gerresheimer AG
  • 31.11. Philip Morris International Inc.
  • 31.12. Oval Medical Technologies Ltd.
  • 31.13. Solteam Incorporation Co. Ltd.
  • 31.14. Elcam Medical Group (E3D) Ltd.
  • 31.15. Jabil Inc.

32. Global Autoinjectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autoinjectors Market

34. Recent Developments In The Autoinjectors Market

35. Autoinjectors Market High Potential Countries, Segments and Strategies

  • 35.1 Autoinjectors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Autoinjectors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Autoinjectors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer